Address & contact
https://oxfordhealth.nhs.uk/ips/ketamine-trd/Specialties
Reports that name this provider
- Ketamine Therapy Availability in United Kingdom
- Operating since at least 2014; longest-running NHS ketamine programme. NHS-funded (limited to Oxfordshire and Buckinghamshire) and self-pay pathways; as of February 2024 no longer accepts NHS-funded referrals from outside these counties. Published outcome data showing mean depression score reductions from 17.5 to 9.2 over 18 months with 49% continuing maintenance treatment. Self-pay: £225/infusion (rising to £265 April 2026), oral ketamine maintenance ~£60/month, esketamine nasal spray £551–£714/dose. Offers IV infusion, oral/sublingual, and nasal spray options. Pioneered by researchers from University of Oxford Department of Psychiatry.
- Psychiatric Care Quality in United Kingdom
- Older People Mental Health Wards won Royal College of Psychiatrists accreditation